Difference between revisions of "Spaeth EL, et al. PLoS ONE (2013) cited as Ref 502 in DOI: 10.1038/s41392-020-0110-5 (Q9765)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 8, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression (English) | ||
| Property / title: Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:03, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Spaeth EL, et al. PLoS ONE (2013) cited as Ref 502 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Spaeth EL
0 references
2013
0 references
PLoS ONE
0 references
8
0 references
Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression (English)
0 references
